Biotech company Novavax reported Monday that Phase 3 trials showed its Covid-19 vaccine to be safe and 100 percent effective in preventing moderate to severe disease. The company's vaccine works differently than the others already authorized for use in the U.S. |
No comments:
Post a Comment